CAAS Capital Management’s Entrada Therapeutics TRDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,000	Closed	-$171K	–	601
2021 Q4	$171K	Buy	+10,000	New	+$171K	﹤0.01%	289